BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tan PL, Bowes Rickman C, Katsanis N. AMD and the alternative complement pathway: genetics and functional implications. Hum Genomics 2016;10:23. [PMID: 27329102 DOI: 10.1186/s40246-016-0079-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Li H, Chintalapudi SR, Jablonski MM. Current drug and molecular therapies for the treatment of atrophic age-related macular degeneration: phase I to phase III clinical development. Expert Opin Investig Drugs 2017;26:1103-14. [PMID: 28816076 DOI: 10.1080/13543784.2017.1369042] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
2 Lashkari K, Teague G, Chen H, Lin YQ, Kumar S, McLaughlin MM, López FJ. A monoclonal antibody targeting amyloid β (Aβ) restores complement factor I bioactivity: Potential implications in age-related macular degeneration and Alzheimer's disease. PLoS One 2018;13:e0195751. [PMID: 29782502 DOI: 10.1371/journal.pone.0195751] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
3 Vocke F, Weisschuh N, Marino V, Malfatti S, Jacobson SG, Reiff CM, Dell'Orco D, Koch KW. Dysfunction of cGMP signalling in photoreceptors by a macular dystrophy-related mutation in the calcium sensor GCAP1. Hum Mol Genet 2017;26:133-44. [PMID: 28025326 DOI: 10.1093/hmg/ddw374] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
4 Nicholson C, Ishii M, Annamalai B, Chandler K, Chwa M, Kenney MC, Shah N, Rohrer B. J or H mtDNA haplogroups in retinal pigment epithelial cells: Effects on cell physiology, cargo in extracellular vesicles, and differential uptake of such vesicles by naïve recipient cells. Biochim Biophys Acta Gen Subj 2021;1865:129798. [PMID: 33217521 DOI: 10.1016/j.bbagen.2020.129798] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kim BJ, Zack DJ. The Role of c-Jun N-Terminal Kinase (JNK) in Retinal Degeneration and Vision Loss. Adv Exp Med Biol 2018;1074:351-7. [PMID: 29721963 DOI: 10.1007/978-3-319-75402-4_43] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Annamalai B, Parsons N, Belhaj M, Brandon C, Potts J, Rohrer B. Encapsulated Cell Technology-Based Delivery of a Complement Inhibitor Reduces Choroidal Neovascularization in a Mouse Model. Transl Vis Sci Technol 2018;7:3. [PMID: 29576927 DOI: 10.1167/tvst.7.2.3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
7 Léveillard T, Klipfel L. Mechanisms Underlying the Visual Benefit of Cell Transplantation for the Treatment of Retinal Degenerations. Int J Mol Sci 2019;20:E557. [PMID: 30696106 DOI: 10.3390/ijms20030557] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Pennington KL, DeAngelis MM. Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors. Eye Vis (Lond) 2016;3:34. [PMID: 28032115 DOI: 10.1186/s40662-016-0063-5] [Cited by in Crossref: 169] [Cited by in F6Publishing: 144] [Article Influence: 28.2] [Reference Citation Analysis]
9 Toomey CB, Landowski M, Klingeborn M, Kelly U, Deans J, Dong H, Harrabi O, Van Blarcom T, Yeung YA, Grishanin R, Lin JC, Saban DR, Bowes Rickman C. Effect of Anti-C5a Therapy in a Murine Model of Early/Intermediate Dry Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci 2018;59:662-73. [PMID: 29392311 DOI: 10.1167/iovs.17-23134] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
10 Kaarniranta K, Pawlowska E, Szczepanska J, Blasiak J. DICER1 in the Pathogenesis of Age-related Macular Degeneration (AMD) - Alu RNA Accumulation versus miRNA Dysregulation. Aging Dis 2020;11:851-62. [PMID: 32765950 DOI: 10.14336/AD.2019.0809] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
11 Saddala MS, Lennikov A, Mukwaya A, Yang X, Tang S, Huang H. Data mining and network analysis reveals C-X-C chemokine receptor type 5 is involved in the pathophysiology of age-related macular degeneration. J Biomol Struct Dyn 2021;:1-10. [PMID: 34243690 DOI: 10.1080/07391102.2021.1949391] [Reference Citation Analysis]
12 Ng CC, Chan CK, Abraham P, Hafner AD. Single nucleotide polymorphism profiles associated with three common phenotypes of advanced age-related macular degeneration. Acta Ophthalmol 2021;99:e133-4. [PMID: 32643258 DOI: 10.1111/aos.14498] [Reference Citation Analysis]
13 Annamalai B, Parsons N, Nicholson C, Joseph K, Coughlin B, Yang X, Jones BW, Tomlinson S, Rohrer B. Natural immunoglobulin M-based delivery of a complement alternative pathway inhibitor in mouse models of retinal degeneration. Exp Eye Res 2021;207:108583. [PMID: 33878326 DOI: 10.1016/j.exer.2021.108583] [Reference Citation Analysis]
14 Jiao H, Rutar M, Fernando N, Yednock T, Sankaranarayanan S, Aggio-Bruce R, Provis J, Natoli R. Subretinal macrophages produce classical complement activator C1q leading to the progression of focal retinal degeneration. Mol Neurodegener 2018;13:45. [PMID: 30126455 DOI: 10.1186/s13024-018-0278-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
15 Kaarniranta K, Tokarz P, Koskela A, Paterno J, Blasiak J. Autophagy regulates death of retinal pigment epithelium cells in age-related macular degeneration. Cell Biol Toxicol 2017;33:113-28. [PMID: 27900566 DOI: 10.1007/s10565-016-9371-8] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 14.3] [Reference Citation Analysis]
16 Jensen EG, Jakobsen TS, Thiel S, Askou AL, Corydon TJ. Associations between the Complement System and Choroidal Neovascularization in Wet Age-Related Macular Degeneration. Int J Mol Sci 2020;21:E9752. [PMID: 33371261 DOI: 10.3390/ijms21249752] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Lauwen S, Baerenfaenger M, Ruigrok S, de Jong EK, Wessels HJCT, den Hollander AI, Lefeber DJ. Loss of the AMD-associated B3GLCT gene affects glycosylation of TSP1 without impairing secretion in retinal pigment epithelial cells. Exp Eye Res 2021;213:108798. [PMID: 34695439 DOI: 10.1016/j.exer.2021.108798] [Reference Citation Analysis]
18 Troldborg A, Jensen L, Deleuran B, Stengaard-Pedersen K, Thiel S, Jensenius JC. The C3dg Fragment of Complement Is Superior to Conventional C3 as a Diagnostic Biomarker in Systemic Lupus Erythematosus. Front Immunol 2018;9:581. [PMID: 29632534 DOI: 10.3389/fimmu.2018.00581] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
19 Sengul EA, Artunay O, Rasier R, Kockar A, Afacan C, Hancer VS, Yuzbasioglu E. Pharmacogenetic Aspect of Intravitreal Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration: A Five-Year Follow-Up. Ocul Immunol Inflamm 2018;26:971-7. [PMID: 28471284 DOI: 10.1080/09273948.2017.1311925] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
20 Bergen AA. Nicotinamide, iRPE-in-a dish, and age-related macular degeneration therapy development. Stem Cell Investig 2017;4:81. [PMID: 29057253 DOI: 10.21037/sci.2017.09.05] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
21 Bowditch E, Chu E, Hong T, Chang AA. Treat and extend paradigm in management of neovascular age-related macular degeneration: current practice and future directions. Expert Review of Ophthalmology 2021;16:267-86. [DOI: 10.1080/17469899.2021.1933439] [Reference Citation Analysis]
22 Riddell N, Crewther SG. Novel evidence for complement system activation in chick myopia and hyperopia models: a meta-analysis of transcriptome datasets. Sci Rep 2017;7:9719. [PMID: 28852117 DOI: 10.1038/s41598-017-10277-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
23 Cheng X, He D, Liao C, Lin S, Tang L, Wang YL, Hu J, Li W, Liu Z, Wu Y, Liao Y. IL-1/IL-1R signaling induced by all-trans-retinal contributes to complement alternative pathway activation in retinal pigment epithelium. J Cell Physiol 2021;236:3660-74. [PMID: 33034385 DOI: 10.1002/jcp.30103] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Parmar VM, Parmar T, Arai E, Perusek L, Maeda A. A2E-associated cell death and inflammation in retinal pigmented epithelial cells from human induced pluripotent stem cells. Stem Cell Res 2018;27:95-104. [PMID: 29358124 DOI: 10.1016/j.scr.2018.01.014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
25 Singh M, Tyagi SC. Genes and genetics in eye diseases: a genomic medicine approach for investigating hereditary and inflammatory ocular disorders. Int J Ophthalmol 2018;11:117-34. [PMID: 29376001 DOI: 10.18240/ijo.2018.01.20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
26 Demirs JT, Yang J, Crowley MA, Twarog M, Delgado O, Qiu Y, Poor S, Rice DS, Dryja TP, Anderson K, Liao SM. Differential and Altered Spatial Distribution of Complement Expression in Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci 2021;62:26. [PMID: 34160562 DOI: 10.1167/iovs.62.7.26] [Reference Citation Analysis]
27 Xiao J, Yao J, Jia L, Lin C, Zacks DN. Protective Effect of Met12, a Small Peptide Inhibitor of Fas, on the Retinal Pigment Epithelium and Photoreceptor After Sodium Iodate Injury. Invest Ophthalmol Vis Sci 2017;58:1801-10. [PMID: 28346613 DOI: 10.1167/iovs.16-21392] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
28 Szakács D, Kocsis A, Szász R, Gál P, Pál G. Novel MASP-2 inhibitors developed via directed evolution of human TFPI1 are potent lectin pathway inhibitors. J Biol Chem 2019;294:8227-37. [PMID: 30952698 DOI: 10.1074/jbc.RA119.008315] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
29 Sarli A, Skalidakis I, Velissari A, Koutsandrea C, Stefaniotou M, Petersen MB, Kroupis C, Kitsos G, Moschos MM. Investigation of associations of ARMS2, CD14, and TLR4 gene polymorphisms with wet age-related macular degeneration in a Greek population. Clin Ophthalmol 2017;11:1347-58. [PMID: 28794612 DOI: 10.2147/OPTH.S134538] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
30 Schnabolk G, Parsons N, Obert E, Annamalai B, Nasarre C, Tomlinson S, Lewin AS, Rohrer B. Delivery of CR2-fH Using AAV Vector Therapy as Treatment Strategy in the Mouse Model of Choroidal Neovascularization. Mol Ther Methods Clin Dev 2018;9:1-11. [PMID: 29234687 DOI: 10.1016/j.omtm.2017.11.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
31 Korb CA, Elbaz H, Schuster AK, Nickels S, Ponto KA, Schulz A, Wild PS, Münzel T, Beutel ME, Schmidtmann I, Lackner KJ, Peto T, Pfeiffer N. Five-year cumulative incidence and progression of age-related macular degeneration: results from the German population-based Gutenberg Health Study (GHS). Graefes Arch Clin Exp Ophthalmol 2021. [PMID: 34424371 DOI: 10.1007/s00417-021-05312-y] [Reference Citation Analysis]
32 Parmeggiani F, Gallenga CE, Costagliola C, Semeraro F, Romano MR, Dell'Omo R, Russo A, De Nadai K, Gemmati D, D'Angelo S, Bolletta E, Sorrentino FS. Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration. Sci Rep 2019;9:2614. [PMID: 30796269 DOI: 10.1038/s41598-019-38919-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
33 Annamalai B, Parsons N, Nicholson C, Obert E, Jones B, Rohrer B. Subretinal Rather Than Intravitreal Adeno-Associated Virus-Mediated Delivery of a Complement Alternative Pathway Inhibitor Is Effective in a Mouse Model of RPE Damage. Invest Ophthalmol Vis Sci 2021;62:11. [PMID: 33830174 DOI: 10.1167/iovs.62.4.11] [Reference Citation Analysis]
34 Kubicka-trząska A, Żuber-łaskawiec K, Dziedzina S, Sanak M, Romanowska-dixon B, Karska-basta I. Genetic Variants of Complement Factor H Y402H (rs1061170), C2 R102G (rs2230199), and C3 E318D (rs9332739) and Response to Intravitreal Anti-VEGF Treatment in Patients with Exudative Age-Related Macular Degeneration. Medicina 2022;58:658. [DOI: 10.3390/medicina58050658] [Reference Citation Analysis]
35 Simmons KT, Mazzilli JL, Mueller-Ortiz SL, Domozhirov AY, Garcia CA, Zsigmond EM, Wetsel RA. Complement Receptor 1 (CR1/CD35)-expressing retinal pigment epithelial cells as a potential therapy for age-related macular degeneration. Mol Immunol 2020;118:91-8. [PMID: 31862673 DOI: 10.1016/j.molimm.2019.11.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
36 Krytkowska E, Ulanczyk Z, Grabowicz A, Mozolewska-Piotrowska K, Safranow K, Palucha A, Krawczyk M, Sikora P, Matczynska E, Stahl A, Machalinski B, Machalinska A. Retinal Vessel Functionality Is Linked With ARMS2 A69S and CFH Y402H Polymorphisms and Choroidal Status in AMD Patients. Invest Ophthalmol Vis Sci 2021;62:30. [PMID: 33900362 DOI: 10.1167/iovs.62.4.30] [Reference Citation Analysis]